These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8256370)

  • 1. [Non-Hodgkin lymphoma in the elderly].
    d'Amore FA; Brincker H; Christensen BE; Thorling K; Pedersen M; Nielsen JL; Sandberg E; Pedersen NT; Sørensen E
    Ugeskr Laeger; 1993 Nov; 155(46):3754-9. PubMed ID: 8256370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group.
    d'Amore F; Brincker H; Christensen BE; Thorling K; Pedersen M; Nielsen JL; Sandberg E; Pedersen NT; Sørensen E
    Ann Oncol; 1992 May; 3(5):379-86. PubMed ID: 1616892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
    Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital.
    Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM
    Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
    Maksymiuk AW; Haines C; Tan LK; Skinnider LF
    Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.
    Economopoulos T; Papageorgiou S; Rontogianni D; Kaloutsi V; Fountzilas G; Tsatalas C; Pavlidis N; Pectasides D; Papageorgiou E; Dimopoulos M;
    Oncologist; 2005 Oct; 10(9):734-8. PubMed ID: 16249354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA
    Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors.
    Bremnes RM; Vik A; Helbekkmo N
    Anticancer Res; 1998; 18(3B):1921-9. PubMed ID: 9677445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
    Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
    Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
    Urquhart A; Berg R
    Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
    Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
    Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
    d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
    J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmic lymphoma: epidemiology and pathogenesis.
    Sjö LD
    Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
    Pulte D; Gondos A; Brenner H
    Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors.
    Meunier J; Lumbroso-Le Rouic L; Vincent-Salomon A; Dendale R; Asselain B; Arnaud P; Fourquet A; Desjardins L; Plancher C; Validire P; Chaoui D; Lévy C; Decaudin D
    Hematol Oncol; 2004 Dec; 22(4):143-58. PubMed ID: 16134191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.